✦ LIBER ✦

Platinum disposition after intraarterial and intravenous infusion of cisplatin for osteosarcoma

✍ Scribed by Stefan S. Bielack; Rudolf Erttmann; Guido Looft; Christine Purfürst; Günther Delling; Kurt Winkler; Günther Landbeck

Book ID: 104687242
Publisher: Springer
Year: 1989
Tongue: English
Weight: 597 KB
Volume: 24
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00257446

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relationship between pharmacokinetics of

Relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity after intravenous infusions of cisplatin to cancer patients

✍ Naomi Nagai; Masafumi Kinoshita; H. Ogata; Daijiro Tsujino; Yuji Wada; Kazuhiko 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 210 KB

Kinetic disposition of morphine in young

Kinetic disposition of morphine in young males after intravenous loading and maintenance infusions

✍ Daniel S. Sitar; Peter C. Duke; James A. Owen; Lisa Berger; Paul A. Mitenko 📂 Article 📅 1986 🏛 Springer-Verlag 🌐 French ⚖ 276 KB

Pharmacokinetics of free and total plati

Pharmacokinetics of free and total platinum species after rapid and prolonged infusions of cisplatin

✍ Vermorken, Jan B; Vijgh, Wim J F Van Der; Gall, Ina Klein, Helen E; Groeningen, 📂 Article 📅 1986 🏛 Nature Publishing Group 🌐 English ⚖ 749 KB

Intraarterial hepatic infusion and intra

Intraarterial hepatic infusion and intravenous adriamycin for treatment of hepatocellular carcinoma. A clinical and pharmacology report

✍ Murray M. Bern; William McDermott Jr.; Blake Cady; Richard A. Oberfield; Charles 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB 👁 2 views

Disposition and Renal Clearance of Propo

Disposition and Renal Clearance of Propofol and its Glucuronide Metabolites after a Short Intravenous Infusion of Propofol

✍ Dr Tom B. Vree, Paul-Michel R. M. de Grood, Herman B. H. van Beem, Leo H. D. J. 📂 Article 📅 1997 🏛 Springer International Publishing AG 🌐 English ⚖ 659 KB

PHARMACOKINETICS OF ELEMENTAL PLATINUM (

PHARMACOKINETICS OF ELEMENTAL PLATINUM (ULTRAFILTRATE AND TOTAL) AFTER A THIRTY MINUTE INTRAVENOUS INFUSION OF ORMAPLATIN

✍ WILLIAM D. FIGG; MICHAELE C. CHRISTIAN; RICHARD LUSH; CHARLES J. LINK; PATRICIA 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB

Preclinical data suggest that ormaplatin (tetrachloro-(d1-trans)-1, 2-diamminocyclohexaneplatinum) has substantial activity in cisplatin-resistant tumor models and may be less nephrotoxic than cisplatin. Based on these data we initiated a phase I clinical trial in patients with refractory metastatic